{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:41:29Z","timestamp":1784194889651,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.vaccine.2007.11.034","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T14:18:19Z","timestamp":1196777899000},"page":"502-508","source":"Crossref","is-referenced-by-count":17,"title":["Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Pia S.","family":"Pannaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia A.","family":"Rench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Madoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morven S.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.11.034_bib1","unstructured":"Centers for Disease Control and Prevention. Early-onset and late-onset neonatal group B streptococcal disease\u2014United States, 1996\u20132004. MMWR Morb Mortal Wkly Rep 2005;54:1205\u20138."},{"key":"10.1016\/j.vaccine.2007.11.034_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM200001063420103","article-title":"Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis","volume":"342","author":"Schrag","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.11.034_bib3","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/j.vaccine.2004.12.021","article-title":"The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis","volume":"23","author":"Sinha","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.034_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1084-2756(02)90114-4","article-title":"Vaccines to prevent neonatal GBS infection","volume":"7","author":"Paoletti","year":"2005","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.vaccine.2007.11.034_bib5","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1172\/JCI119042","article-title":"Immune response to type III group B streptococcal polysaccharide\u2013tetanus toxoid conjugate vaccine","volume":"98","author":"Kasper","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.11.034_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JCM.19.4.506-510.1984","article-title":"Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes","volume":"19","author":"Johnson","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.11.034_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2334-6-116","article-title":"The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates","volume":"6","author":"Manning","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.034_bib8","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1073\/pnas.89.21.10060","article-title":"Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci","volume":"89","author":"Michel","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2007.11.034_bib9","doi-asserted-by":"crossref","first-page":"24714","DOI":"10.1074\/jbc.M402164200","article-title":"Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism","volume":"279","author":"Baron","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.11.034_bib10","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1074\/jbc.M608279200","article-title":"Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B streptococci into host cells","volume":"282","author":"Baron","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2007.11.034_bib11","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/IAI.67.5.2491-2496.1999","article-title":"Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines","volume":"67","author":"Gravekamp","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.034_bib12","first-page":"113","article-title":"The Ibc proteins of group B streptococci: isolation of the \u03b1 and \u03b2 antigens by immunosorbent chromatography and test for human serum antibodies against the two antigens","volume":"93","author":"Bevanger","year":"1985","journal-title":"Acta Path Microbiol Immunol Scand"},{"key":"10.1016\/j.vaccine.2007.11.034_bib13","doi-asserted-by":"crossref","first-page":"F403","DOI":"10.1136\/adc.2005.090472","article-title":"Association between low concentrations of antibodies to protein \u03b1 and Rib and invasive neonatal group B streptococcal infection","volume":"91","author":"Larsson","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.vaccine.2007.11.034_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0029-7844(00)00977-7","article-title":"Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery","volume":"96","author":"Campbell","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2007.11.034_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.59.4.441","article-title":"Serologic differentiation of specific types of bovine hemolytic streptococci","volume":"59","author":"Lancefield","year":"1934","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.11.034_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1078\/1438-4221-00188","article-title":"Improved methods for typing nontypeable isolates of group B Streptococcus","volume":"292","author":"Benson","year":"2002","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2007.11.034_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1086\/510627","article-title":"Group B Streptococcus bacteremia elicits beta C protein-specific IgM and IgG in humans","volume":"195","author":"Pannaraj","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.034_bib18","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1128\/IAI.64.9.3576-3583.1996","article-title":"Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes","volume":"64","author":"Gravekamp","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.034_bib19","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.02236-05","article-title":"Molecular characterization of nontypeable group B Streptococcus","volume":"44","author":"Ramaswamy","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.11.034_bib20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/infdis\/140.6.1004","article-title":"Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus","volume":"140","author":"Edwards","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.034_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.142.1.165","article-title":"Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens","volume":"142","author":"Lancefield","year":"1975","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.11.034_bib22","first-page":"121","article-title":"Mouse-protective antibodies against the Ibc proteins of group B streptococci","volume":"93","author":"Bevanger","year":"1985","journal-title":"Acta Pathol Microbiol Immunol Scand [B]"},{"key":"10.1016\/j.vaccine.2007.11.034_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1128\/IAI.59.1.204-210.1991","article-title":"A monoclonal antibody identified a protective C-protein alpha-antigen epitope in group B streptococci","volume":"59","author":"Madoff","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.034_bib24","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/IAI.59.6.2023-2028.1991","article-title":"Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity","volume":"59","author":"Michel","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.034_bib25","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/IAI.64.9.3518-3523.1996","article-title":"Experimental vaccination against Group B Streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins rib and \u03b1","volume":"64","author":"Larsson","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.034_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.11.034_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0022-3476(84)80436-9","article-title":"Quantitation of IgG antibody to the type-specific polysaccharide of group B Streptococcus type 1b in pregnant women and infected infants","volume":"105","author":"Gotoff","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2007.11.034_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/322029","article-title":"Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate","volume":"184","author":"Davies","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.11.034_bib29","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1073\/pnas.93.9.4131","article-title":"Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein","volume":"93","author":"Madoff","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2007.11.034_bib30","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/IAI.59.8.2638-2644.1991","article-title":"Phenotypic diversity in the alpha C protein of Group B streptococci","volume":"59","author":"Madoff","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.11.034_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1086\/515260","article-title":"Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation","volume":"177","author":"Harrison","year":"1998","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07013333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T03:56:34Z","timestamp":1588132594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07013333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0264410X07013333"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}